Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WM8D
|
|||
| Drug Name |
CAD-1833
|
|||
| Indication | Essential tremor or related tremors [ICD-11: 8A04.1; ICD-10: G25.0] | Phase 1 | [1] | |
| Spinocerebellar ataxia [ICD-11: 8A03.16] | Phase 1 | [1] | ||
| Company |
Cadent Therapeutics Cambridge, MA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calcium-activated potassium channel KCa2 (KCNN) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.